DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Joseph JD, Lu N, Qian J. , et al.
A clinically relevant androgen receptor mutation confers resistance to second-generation antiandrogens enzalutamide and ARN-509.
Cancer Discov 2013;
3 (09) 1020-1029
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.